Article Details
Retrieved on: 2021-03-25 14:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The litigation, which has been ongoing since late 2014, centers on patents covering PCSK9 inhibitor monoclonal antibody drugs for lowering ...
Article found on: www.biopharma-reporter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here